Nevanlinna H - Search Results

1

Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women.

Rebbeck TR, Friebel TM, Mitra N, Wan F, Chen S, Andrulis IL, Apostolou P, Arnold N, Arun BK, Barrowdale D, Benitez J, Berger R, Berthet P, Borg A, Buys SS, Caldes T, Carter J, Chiquette J, Claes KB, Couch FJ, Cybulski C, Daly MB, de la Hoya M, Diez O, Domchek SM, Nathanson KL, Durda K, Ellis S; EMBRACE; Evans DG, Foretova L, Friedman E, Frost D, Ganz PA, Garber J, Glendon G, Godwin AK, Greene MH, Gronwald J, Hahnen E, Hallberg E, Hamann U, Hansen TV; HEBON; Imyanitov EN, Isaacs C, Jakubowska A, Janavicius R, Jaworska-Bieniek K, John EM, Karlan BY, Kaufman B, Investigators K, Kwong A, Laitman Y, Lasset C, Lazaro C, Lester J, Loman N, Lubinski J, Manoukian S, Mitchell G, Montagna M, Neuhausen SL, Nevanlinna H, Niederacher D, Nussbaum RL, Offit K, Olah E, Olopade OI, Park SK, Piedmonte M, Radice P, Rappaport-Fuerhauser C, Rookus MA, Seynaeve C, Simard J, Singer CF, Soucy P, Southey M, Stoppa-Lyonnet D, Sukiennicki G, Szabo CI, Tancredi M, Teixeira MR, Teo SH, Terry MB, Thomassen M, Tihomirova L, Tischkowitz M, Toland AE, Toloczko-Grabarek A, Tung N, van Rensburg EJ, Villano D, Wang-Gohrke S, Wappenschmidt B, Weitzel JN, Zidan J, Zorn KK, McGuffog L, Easton D, Chenevix-Trench G… See abstract for full author list ➔ Rebbeck TR, et al. Among authors: nevanlinna h. Breast Cancer Res. 2016 Nov 11;18(1):112. doi: 10.1186/s13058-016-0768-3. Breast Cancer Res. 2016. PMID: 27836010 Free PMC article.

2

Evidence for involvement of BRCA1 in sporadic breast carcinomas.

Cropp CS, Nevanlinna HA, Pyrhönen S, Stenman UH, Salmikangas P, Albertsen H, White R, Callahan R. Cropp CS, et al. Among authors: nevanlinna ha. Cancer Res. 1994 May 15;54(10):2548-51. Cancer Res. 1994. PMID: 8168077

3

A low proportion of BRCA2 mutations in Finnish breast cancer families.

Vehmanen P, Friedman LS, Eerola H, Sarantaus L, Pyrhönen S, Ponder BA, Muhonen T, Nevanlinna H. Vehmanen P, et al. Among authors: nevanlinna h. Am J Hum Genet. 1997 May;60(5):1050-8. Am J Hum Genet. 1997. PMID: 9150152 Free PMC article.

4

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.

Vehmanen P, Friedman LS, Eerola H, McClure M, Ward B, Sarantaus L, Kainu T, Syrjäkoski K, Pyrhönen S, Kallioniemi OP, Muhonen T, Luce M, Frank TS, Nevanlinna H. Vehmanen P, et al. Among authors: nevanlinna h. Hum Mol Genet. 1997 Dec;6(13):2309-15. doi: 10.1093/hmg/6.13.2309. Hum Mol Genet. 1997. PMID: 9361038

5

A missense mutation in the BRCA2 gene in three siblings with ovarian cancer.

Roth S, Kristo P, Auranen A, Shayehgi M, Seal S, Collins N, Barfoot R, Rahman N, Klemi PJ, Grénman S, Sarantaus L, Nevanlinna H, Butzow R, Ashworth A, Stratton MR, Aaltonen LA. Roth S, et al. Among authors: nevanlinna h. Br J Cancer. 1998 Apr;77(8):1199-202. doi: 10.1038/bjc.1998.202. Br J Cancer. 1998. PMID: 9579822 Free PMC article.

6

Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hybridization: extensive similarity except for a difference at chromosome 2q24-q32.

Tapper J, Sarantaus L, Vahteristo P, Nevanlinna H, Hemmer S, Seppälä M, Knuutila S, Butzow R. Tapper J, et al. Among authors: nevanlinna h. Cancer Res. 1998 Jul 1;58(13):2715-9. Cancer Res. 1998. PMID: 9661879

7

Cancer risks in BRCA2 mutation carriers.

Breast Cancer Linkage Consortium. Breast Cancer Linkage Consortium. J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6. doi: 10.1093/jnci/91.15.1310. J Natl Cancer Inst. 1999. PMID: 10433620

8

Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients.

Syrjäkoski K, Vahteristo P, Eerola H, Tamminen A, Kivinummi K, Sarantaus L, Holli K, Blomqvist C, Kallioniemi OP, Kainu T, Nevanlinna H. Syrjäkoski K, et al. Among authors: nevanlinna h. J Natl Cancer Inst. 2000 Sep 20;92(18):1529-31. doi: 10.1093/jnci/92.18.1529. J Natl Cancer Inst. 2000. PMID: 10995809 No abstract available.

9

Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.

Sarantaus L, Huusko P, Eerola H, Launonen V, Vehmanen P, Rapakko K, Gillanders E, Syrjäkoski K, Kainu T, Vahteristo P, Krahe R, Pääkkönen K, Hartikainen J, Blomqvist C, Löppönen T, Holli K, Ryynänen M, Bützow R, Borg A, Wasteson Arver B, Holmberg E, Mannermaa A, Kere J, Kallioniemi OP, Winqvist R, Nevanlinna H. Sarantaus L, et al. Among authors: nevanlinna h. Eur J Hum Genet. 2000 Oct;8(10):757-63. doi: 10.1038/sj.ejhg.5200529. Eur J Hum Genet. 2000. PMID: 11039575

10

Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites.

Rapakko K, Allinen M, Syrjäkoski K, Vahteristo P, Huusko P, Vähäkangas K, Eerola H, Kainu T, Kallioniemi OP, Nevanlinna H, Winqvist R. Rapakko K, et al. Among authors: nevanlinna h. Br J Cancer. 2001 Jan 5;84(1):116-9. doi: 10.1054/bjoc.2000.1530. Br J Cancer. 2001. PMID: 11139324 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters